Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth

Hanahan, 2011, Hallmarks of cancer: The next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 Vesely, 2013, Cancer immunoediting: Antigens, mechanisms, and implications to cancer immunotherapy, Ann N Y Acad Sci, 1284, 1, 10.1111/nyas.12105 Maris, 2010, Recent advances in neuroblastoma, N Engl J Med, 362, 2202, 10.1056/NEJMra0804577 Matthay, 2016, Neuroblastoma, Nat Rev Dis Primers, 2, 10.1038/nrdp.2016.78 Carén, 2010, High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset, Proc Natl Acad Sci USA, 107, 4323, 10.1073/pnas.0910684107 Asgharzadeh, 2012, Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma, J Clin Oncol, 30, 3525, 10.1200/JCO.2011.40.9169 Cheung, 2013, Neuroblastoma: Developmental biology, cancer genomics and immunotherapy, Nat Rev Cancer, 13, 397, 10.1038/nrc3526 Mao, 2016, Targeting suppressive myeloid cells potentiates checkpoint inhibitors to control spontaneous neuroblastoma, Clin Cancer Res, 22, 3849, 10.1158/1078-0432.CCR-15-1912 Pistoia, 2013, Immunosuppressive microenvironment in neuroblastoma, Front Oncol, 3, 10.3389/fonc.2013.00167 Liu, 2015, Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity, Cancer Cell Int, 15, 10.1186/s12935-015-0260-7 Nakanishi, 2013, Multifaceted roles of PGE2 in inflammation and cancer, Semin Immunopathol, 35, 123, 10.1007/s00281-012-0342-8 Sinha, 2007, Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells, Cancer Res, 67, 4507, 10.1158/0008-5472.CAN-06-4174 Brocard, 2015, Radiation-induced PGE2 sustains human glioma cells growth and survival through EGF signaling, Oncotarget, 6, 6840, 10.18632/oncotarget.3160 Kurtova, 2015, Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance, Nature, 517, 209, 10.1038/nature14034 Finetti, 2012, Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis, PLoS One, 7, 10.1371/journal.pone.0040576 Hanaka, 2009, Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells, Proc Natl Acad Sci USA, 106, 18757, 10.1073/pnas.0910218106 Kamei, 2010, Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis, Biochem J, 425, 361, 10.1042/BJ20090045 Samuelsson, 2007, Membrane prostaglandin E synthase-1: A novel therapeutic target, Pharmacol Rev, 59, 207, 10.1124/pr.59.3.1 Wang, 2010, Eicosanoids and cancer, Nat Rev Cancer, 10, 181, 10.1038/nrc2809 Zelenay, 2015, Cyclooxygenase-dependent tumor growth through evasion of immunity, Cell, 162, 1257, 10.1016/j.cell.2015.08.015 Pawelzik, 2010, Identification of key residues determining species differences in inhibitor binding of microsomal prostaglandin E synthase-1, J Biol Chem, 285, 29254, 10.1074/jbc.M110.114454 Leclerc, 2013, Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation, Prostaglandins Other Lipid Mediat, 107, 26, 10.1016/j.prostaglandins.2013.09.001 Leclerc, 2013, Characterization of a new mPGES-1 inhibitor in rat models of inflammation, Prostaglandins Other Lipid Mediat, 102–103, 1, 10.1016/j.prostaglandins.2013.03.005 Larsson, 2015, COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset, Proc Natl Acad Sci USA, 112, 8070, 10.1073/pnas.1424355112 Gotwals, 2017, Prospects for combining targeted and conventional cancer therapy with immunotherapy, Nat Rev Cancer, 17, 286, 10.1038/nrc.2017.17 Johnsen, 2004, Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo, Cancer Res, 64, 7210, 10.1158/0008-5472.CAN-04-1795 Idborg, 2013, Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice, Prostaglandins Other Lipid Mediat, 107, 18, 10.1016/j.prostaglandins.2013.07.004 Melin, 2014, Elevated expression of prostaglandin E2 synthetic pathway in skeletal muscle of prior polio patients, J Rehabil Med, 46, 67, 10.2340/16501977-1230 Kryh, 2011, Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors, BMC Genomics, 12, 10.1186/1471-2164-12-443 Rasmuson, 2012, Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma, PLoS One, 7, 10.1371/journal.pone.0051297 Weiss, 1997, Targeted expression of MYCN causes neuroblastoma in transgenic mice, EMBO J, 16, 2985, 10.1093/emboj/16.11.2985 Yu, 2009, STATs in cancer inflammation and immunity: A leading role for STAT3, Nat Rev Cancer, 9, 798, 10.1038/nrc2734 Olesch, 2015, MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer, Oncotarget, 6, 10284, 10.18632/oncotarget.3581 Carlson, 2013, Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma, Carcinogenesis, 34, 1081, 10.1093/carcin/bgt009 Baryawno, 2008, Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets, Neuro-Oncology, 10, 661, 10.1215/15228517-2008-035 Uracz, 2002, Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells, J Physiol Pharmacol, 53, 643 Rasmuson, 2012, Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma, PLoS One, 7, 10.1371/journal.pone.0029331 Borriello, 2015, More than the genes, the tumor microenvironment in neuroblastoma, Cancer Lett, 380, 304, 10.1016/j.canlet.2015.11.017 Jain, 2008, Prostaglandin E2 regulates tumor angiogenesis in prostate cancer, Cancer Res, 68, 7750, 10.1158/0008-5472.CAN-07-6689 Ponthan, 2007, Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo, Clin. Cancer Res., 13, 1036, 10.1158/1078-0432.CCR-06-1908 Xu, 2014, COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models, Sci Transl Med, 6, 10.1126/scitranslmed.3008455 Gascard, 2016, Carcinoma-associated fibroblasts: Orchestrating the composition of malignancy, Genes Dev, 30, 1002, 10.1101/gad.279737.116 Takahashi, 2017, Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages, Oncotarget, 8, 8633, 10.18632/oncotarget.14374